Harmony Biosciences Management, Inc.

Quick facts

Phase 3 pipeline

• Double-blind pitolisant · Neurology
  Pitolisant is a selective histamine H3 receptor antagonist that increases wakefulness by blocking inhibitory histamine signaling in the brain.
• Open-label pitolisant · Neurology
  Pitolisant is a selective histamine H3 receptor antagonist that increases wakefulness by blocking inhibitory histamine signaling in the brain.
• Pitolisant tablet · Neurology
  Pitolisant is a selective histamine H3 receptor antagonist that increases histamine release in the brain to promote wakefulness.

Phase 2 pipeline

• Pitolisant oral tablets
• ZYN002

Phase 1 pipeline

• HBS-201

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Harmony Biosciences Management, Inc. portfolio CI brief
• Harmony Biosciences Management, Inc. pipeline updates RSS